Name: IDXX Income Statement - Idexx Laboratories Inc. /de Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

IDXX - Idexx Laboratories Inc. /de

USD|NASDAQ|Healthcare

IDXX Income Statement - Idexx Laboratories Inc. /de Revenue & EPS | Ledgeburg

(USD in millions, except per-share data and share counts)	Q2 FY 2630 Jun 2026	Q1 FY 2631 Mar 2026	Q4 FY 2531 Dec 2025	Q3 FY 2530 Sep 2025	Q2 FY 2530 Jun 2025	Q1 FY 2531 Mar 2025	Q4 FY 2431 Dec 2024	Q3 FY 2430 Sep 2024	Q2 FY 2430 Jun 2024	Q1 FY 2431 Mar 2024	Q4 FY 2331 Dec 2023	Q3 FY 2330 Sep 2023	Q2 FY 2330 Jun 2023	Q1 FY 2331 Mar 2023	Q4 FY 2231 Dec 2022	Q3 FY 2230 Sep 2022	Q2 FY 2230 Jun 2022	Q1 FY 2231 Mar 2022	Q4 FY 2131 Dec 2021	Q3 FY 2130 Sep 2021	Q2 FY 2130 Jun 2021	Q1 FY 2131 Mar 2021	Q4 FY 2031 Dec 2020	Q3 FY 2030 Sep 2020	Q2 FY 2030 Jun 2020	Q1 FY 2031 Mar 2020	Q4 FY 1931 Dec 2019	Q3 FY 1930 Sep 2019	Q2 FY 1930 Jun 2019	Q1 FY 1931 Mar 2019	Q4 FY 1831 Dec 2018	Q3 FY 1830 Sep 2018	Q2 FY 1830 Jun 2018	Q1 FY 1831 Mar 2018	Q4 FY 1731 Dec 2017	Q3 FY 1730 Sep 2017	Q2 FY 1730 Jun 2017	Q1 FY 1731 Mar 2017	Q4 FY 1631 Dec 2016	Q3 FY 1630 Sep 2016
Revenues
Revenues	1,216.6	1,140.8	1,090.6	1,105.2	1,109.5	998.4	954.3	975.5	1,003.6	964.1	901.6	915.5	943.6	900.2	828.6	841.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Most recent period as filed 4 August 2026, reported in USD. Period end dates link to the filing on SEC EDGAR.

(USD in millions, except per-share data and share counts)	TTM30 Jun 2026	FY202531 Dec 2025	FY202431 Dec 2024	FY202331 Dec 2023	FY202231 Dec 2022	FY202131 Dec 2021	FY202031 Dec 2020	FY201931 Dec 2019	FY201831 Dec 2018	FY201731 Dec 2017	FY201631 Dec 2016	FY201531 Dec 2015	FY201431 Dec 2014	FY201331 Dec 2013	FY201231 Dec 2012	FY201131 Dec 2011	FY201031 Dec 2010	FY200931 Dec 2009	FY200831 Dec 2008
Revenues
Revenues	4,553.2	4,303.7	3,897.5	3,661.0	3,367.3	3,215.4	2,706.7	2,406.9	2,213.2	1,969.1	1,775.4	1,601.9	1,485.8	1,377.1	1,293.3	1,218.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Most recent period as filed 20 February 2026, reported in USD. Period end dates link to the filing on SEC EDGAR.

Operating Expenses
Research & Development	65.4	65.8	66.8	63.4	61.9	59.1	57.7	54.0	55.5	52.6	51.8	48.0	46.5	44.7	43.4	48.0	123.2	40.2	45.3	40.4	37.7	37.6	38.8	37.5	31.6	33.3	35.2	34.3	32.3	31.5	30.1	29.2	29.5	29.0	28.8	27.6	27.0	25.8	25.4	25.7
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	171.3	175.3	167.1	159.2	161.1	156.2	150.1	146.3	142.7	149.5	142.0	135.7	140.5	147.8	131.9	130.0	130.3
General & Administrative	116.8	119.1	108.6	105.9	98.7	91.6	101.1	91.9	157.2	92.0	87.0	89.0	89.7	70.1	83.0	83.8	81.5
Depreciation & Amortization	-	37.7	-	-	-	34.1	-	-	-	29.9	-	-	-	28.3	-	-
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	353.5	360.2	342.5	328.5	321.7	306.8	309.0	292.1	355.4	294.1	-	-	-	-	-	-

Operating Income
Operating Income	425.6	362.6	315.6	354.8	373.0	316.5	261.7	303.9	263.8	299.0	245.3	275.3	296.1	280.4	226.5	244.8	179.1	248.3	199.2	226.0	259.3	247.6	185.1	171.9	193.2	144.3	115.6	139.8	164.3	133.1	115.3	117.4	145.6	113.0	97.8	100.4	122.6	92.2	83.8	88.5

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	10.2	7.7	9.2	10.7	11.3	7.7	7.5	7.7	8.1	7.9	9.3	8.6	10.5	13.1	13.5	11.0	8.3	7.0
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pre-Tax Income	417.2	355.4	307.0	344.8	362.4	310.1	256.4	298.9	259.1	295.5	239.7	267.9	285.9	267.7	213.2	234.2

Tax & Net
Income Tax Expense	78.8	77.0	58.8	70.2	68.4	67.4	40.2	66.1	55.8	59.9	45.1	55.7	61.7	53.6	41.0	53.2	39.1	47.5	29.1	43.8	49.1	35.8	2.5	17.6	34.8	24.9	18.0	24.0	30.4	22.1	21.4	15.8	28.6	14.9	51.4	21.5	29.2	15.7	24.8	25.1
Net Income From Continuing Ops	338.4	278.4	248.2	274.6	294.0	242.7	216.1	232.8	203.3	235.6	194.5	212.2	224.2	214.1	172.2	180.9	132.0
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	338.4	278.4	248.2	274.6	294.0	242.7	216.1	232.8	203.3	235.6	194.5	212.2	224.2	214.1	172.2	180.9	132.0
Net Income Attributable To Parent	338.4	278.4	248.2	274.6	294.0	242.7	216.1	232.8	203.3	235.6	194.5	212.2	224.2	214.1	172.2	180.9
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	0.0	0.0
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	338.4	278.4	248.2	274.6	294.0	242.7	216.1	232.8	203.3	235.6	194.5	212.2	224.2	214.1	172.2

Per Share
EPS Basic	4.29	3.50	-	3.43	3.66	2.98	-	2.83	2.46	2.84	-	2.55	2.70	2.58	-	2.17	1.57	2.30	-	2.06	2.37	2.39	-	1.71	1.75	1.31	-	1.26	1.46	1.19	-	1.07	1.25	1.02	-	0.81	0.97	0.78	-	0.63
EPS Diluted	4.27	3.47	-	3.40	3.63	2.96	-	2.80	2.44	2.81	-	2.53	2.67	2.55	-	2.15	1.56	2.27
Shares Basic	79.0	79.6	-	80.1	80.4	81.3	-	82.3	82.6	83.1	-	83.1	83.1	83.0	-	83.2	83.9	84.4
Shares Diluted	79.3	80.2	-	80.7	81.0	81.9	-	83.1	83.4	84.0	-	84.0	84.0	84.0	-	84.1	84.9	85.6

Supplementary Data
EBITDA	-	400.3	-	-	-	350.6	-	-	-	328.9	-	-	-	308.7	-	-	-	274.9	-	-	-	272.7	-	-	-	167.5	-	-	-	154.5	-	-	-	133.8	-	-	-	112.6	-	-
EBIT	425.6	362.6	315.6	354.8	373.0	316.5	261.7	303.9	263.8	299.0	245.3	275.3	296.1	280.4	226.5	244.8	179.1	248.3	199.2

Operating Expenses
Research & Development	261.5	251.2	219.8	191.0	254.8	161.0	141.2	133.2	117.9	109.2	101.1	99.7	98.3	88.0	82.0	76.0	68.6	65.1	70.7
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	672.7	643.5	588.5	566.1	524.5	486.7	434.4	418.2	387.4	354.3	317.1	300.0	283.7	243.5	217.0	204.9	179.6
General & Administrative	450.5	404.8	442.3	335.8	326.2	309.7	300.8	261.3	244.9	220.9	207.0	182.5	173.9	157.9	137.6	129.4
Depreciation & Amortization	-	145.2	129.9	114.9	111.9	104.6	96.0	88.0	83.2	83.1	78.2	69.0	58.9	54.6	52.4	48.2
Amortization of Intangibles	-	20.2	17.1	13.8	15.0	12.1	9.8	9.4	8.9	9.0	9.5	10.4	9.8	9.7	9.8	8.7	9.0
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	1,384.7	1,299.5	1,250.6	1,092.8	1,105.6	-	-	-	750.2	-	-	-	-	-	-	-

Operating Income
Operating Income	1,458.6	1,360.0	1,128.3	1,097.1	898.8	932.0	694.5	552.8	491.3	413.0	350.2	299.9	260.3	266.8	262.6	236.2	203.9	176.0	172.5

Tax & Net
Income Tax Expense	284.8	264.7	222.0	216.1	180.9	157.8	79.9	94.4	80.7	117.8	99.8	81.0	64.6	75.5	82.3	72.7	60.8	52.3	54.0
Net Income From Continuing Ops	1,139.7	1,059.5	887.9	845.0	679.1	744.8	582.1	427.8	377.0	263.3	222.1	192.1	182.0	187.8	178.3	161.8	141.3
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	1,139.7	1,059.5	887.9	845.0	679.1	744.8	582.1	427.8	377.0	263.3	222.1	192.1	182.0	187.8	178.3	161.8	141.3
Net Income Attributable To Parent	1,139.7	1,059.5	887.9	845.0	679.1	744.8	581.8	427.7	377.0	263.1	222.0	192.1	181.9	187.8	178.3	161.8
Less: Minority Interest	-	-	-	0.0	0.0	(0.0)	0.4	0.1	0.0	0.1	0.0	0.1	0.0	(0.0)	0.0	(0.0)	0.0
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	1,139.7	1,059.5	887.9	845.0	679.1	744.8	581.8	427.7	377.0	263.1	222.0	192.1	181.9	187.8	178.3

Per Share
EPS Basic	14.43	13.17	10.77	10.17	8.12	8.74	6.82	4.97	4.34	3.00	2.47	2.07	1.82	1.77	3.24	2.85	2.45	2.08	1.94
EPS Diluted	14.37	13.08	10.67	10.06	8.03	8.60	6.71	4.89	4.26	2.94	2.44	2.05	1.79	1.74	3.17	2.78	2.37	2.01
Shares Basic	79.0	80.4	82.5	83.1	83.6	85.2	85.3	86.1	86.9	87.8	89.7	92.6	100.1	106.3	55.0	56.8	57.7	58.8
Shares Diluted	79.3	81.0	83.2	84.0	84.6	86.6	86.7	87.5	88.5	89.6	90.9	93.6	101.5	108.0	56.2	58.2	59.6	60.7

Supplementary Data
EBITDA	-	1,505.2	1,258.3	1,212.0	1,010.7	1,036.6	790.5	640.9	574.5	496.2	428.5	368.9	319.1	321.4	315.0	284.4	249.8	225.7	220.4
EBIT	1,458.6	1,360.0	1,128.3	1,097.1	898.8	932.0	694.5	552.8	491.3	413.0	350.2	299.9	260.3	266.8	262.6	236.2	203.9	176.0	172.5